Your browser doesn't support javascript.
loading
An open, prospective cohort study of VV116 in Chinese participants infected with SARS-CoV-2 omicron variants.
Shen, Yinzhong; Ai, Jingwen; Lin, Na; Zhang, Haocheng; Li, Yang; Wang, Hongyu; Wang, Sen; Wang, Zhen; Li, Tao; Sun, Feng; Fan, Zhenyu; Li, Liqun; Lu, Yunfei; Meng, Xianmin; Xiao, Hong; Hu, Huiliang; Ling, Yun; Li, Feng; Li, Hongdi; Xi, Chunmei; Gu, Liping; Zhang, Wenhong; Fan, Xiaohong.
Afiliación
  • Shen Y; Department of Infection and Immunity, Shanghai Public Health Clinical Centre, Fudan University, Shanghai, People's Republic of China.
  • Ai J; Department of Infectious Diseases, National Medical Centre for Infectious Diseases, National Clinical Research Centre for Aging and Medicine, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Huashan Hospital, Fudan University, Shanghai, People's Republic of China.
  • Lin N; Department of COVID-19, Shanghai Public Health Clinical Centre, Fudan University, Shanghai, People's Republic of China.
  • Zhang H; Department of Infectious Diseases, National Medical Centre for Infectious Diseases, National Clinical Research Centre for Aging and Medicine, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Huashan Hospital, Fudan University, Shanghai, People's Republic of China.
  • Li Y; Department of Infectious Diseases, National Medical Centre for Infectious Diseases, National Clinical Research Centre for Aging and Medicine, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Huashan Hospital, Fudan University, Shanghai, People's Republic of China.
  • Wang H; Department of Infectious Diseases, National Medical Centre for Infectious Diseases, National Clinical Research Centre for Aging and Medicine, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Huashan Hospital, Fudan University, Shanghai, People's Republic of China.
  • Wang S; Department of Infectious Diseases, National Medical Centre for Infectious Diseases, National Clinical Research Centre for Aging and Medicine, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Huashan Hospital, Fudan University, Shanghai, People's Republic of China.
  • Wang Z; Lingang Laboratory, Shanghai, People's Republic of China.
  • Li T; Department of Tuberculosis, Shanghai Public Health Clinical Centre, Fudan University, Shanghai, People's Republic of China.
  • Sun F; Department of Infectious Diseases, National Medical Centre for Infectious Diseases, National Clinical Research Centre for Aging and Medicine, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Huashan Hospital, Fudan University, Shanghai, People's Republic of China.
  • Fan Z; Department of COVID-19, Shanghai Public Health Clinical Centre, Fudan University, Shanghai, People's Republic of China.
  • Li L; Department of COVID-19, Shanghai Public Health Clinical Centre, Fudan University, Shanghai, People's Republic of China.
  • Lu Y; Department of COVID-19, Shanghai Public Health Clinical Centre, Fudan University, Shanghai, People's Republic of China.
  • Meng X; Department of COVID-19, Shanghai Public Health Clinical Centre, Fudan University, Shanghai, People's Republic of China.
  • Xiao H; Department of COVID-19, Shanghai Public Health Clinical Centre, Fudan University, Shanghai, People's Republic of China.
  • Hu H; Department of COVID-19, Shanghai Public Health Clinical Centre, Fudan University, Shanghai, People's Republic of China.
  • Ling Y; Department of Infectious Diseases, Shanghai Public Health Clinical Centre, Fudan University, Shanghai, People's Republic of China.
  • Li F; Department of Respiratory Diseases, Shanghai Public Health Clinical Centre, Fudan University, Shanghai, People's Republic of China.
  • Li H; Department of COVID-19, Shanghai Public Health Clinical Centre, Fudan University, Shanghai, People's Republic of China.
  • Xi C; Department of COVID-19, Shanghai Public Health Clinical Centre, Fudan University, Shanghai, People's Republic of China.
  • Gu L; Department of COVID-19, Shanghai Public Health Clinical Centre, Fudan University, Shanghai, People's Republic of China.
  • Zhang W; Department of Infectious Diseases, National Medical Centre for Infectious Diseases, National Clinical Research Centre for Aging and Medicine, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Huashan Hospital, Fudan University, Shanghai, People's Republic of China.
  • Fan X; Department of Tuberculosis, Shanghai Public Health Clinical Centre, Fudan University, Shanghai, People's Republic of China.
Emerg Microbes Infect ; 11(1): 1518-1523, 2022 Dec.
Article en En | MEDLINE | ID: mdl-35579892
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: SARS-CoV-2 / Tratamiento Farmacológico de COVID-19 Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Emerg Microbes Infect Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: SARS-CoV-2 / Tratamiento Farmacológico de COVID-19 Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Emerg Microbes Infect Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos